nodes	percent_of_prediction	percent_of_DWPC	metapath
Duloxetine—CYP1A2—Nicotine—ulcerative colitis	0.019	0.347	CbGbCtD
Duloxetine—CYP2D6—Nicotine—ulcerative colitis	0.0157	0.286	CbGbCtD
Duloxetine—CYP2D6—Cholecalciferol—ulcerative colitis	0.014	0.256	CbGbCtD
Duloxetine—HTR2A—enteric nervous system—ulcerative colitis	0.00954	0.393	CbGeAlD
Duloxetine—HTR2A—myenteric nerve plexus—ulcerative colitis	0.00723	0.298	CbGeAlD
Duloxetine—CYP2D6—Dexamethasone—ulcerative colitis	0.00608	0.111	CbGbCtD
Duloxetine—NPY1R—liver—ulcerative colitis	0.002	0.0824	CbGeAlD
Duloxetine—Protriptyline—ABCB1—ulcerative colitis	0.00127	0.268	CrCbGaD
Duloxetine—Propranolol—ADRB2—ulcerative colitis	0.00116	0.245	CrCbGaD
Duloxetine—SLC6A4—digestive system—ulcerative colitis	0.00104	0.0426	CbGeAlD
Duloxetine—Fluoxetine—ALB—ulcerative colitis	0.000909	0.192	CrCbGaD
Duloxetine—Fluoxetine—ABCB1—ulcerative colitis	0.000868	0.183	CrCbGaD
Duloxetine—HTR2A—epithelium—ulcerative colitis	0.00072	0.0297	CbGeAlD
Duloxetine—CYP1A2—digestive system—ulcerative colitis	0.000701	0.0289	CbGeAlD
Duloxetine—HTR2A—smooth muscle tissue—ulcerative colitis	0.000694	0.0286	CbGeAlD
Duloxetine—HTR2A—digestive system—ulcerative colitis	0.000548	0.0226	CbGeAlD
Duloxetine—Propranolol—ABCB1—ulcerative colitis	0.00053	0.112	CrCbGaD
Duloxetine—CYP1A2—liver—ulcerative colitis	0.000522	0.0215	CbGeAlD
Duloxetine—CYP2D6—digestive system—ulcerative colitis	0.000499	0.0206	CbGeAlD
Duloxetine—HTR2A—liver—ulcerative colitis	0.000408	0.0168	CbGeAlD
Duloxetine—CYP2D6—liver—ulcerative colitis	0.000372	0.0153	CbGeAlD
Duloxetine—Myalgia—Triamcinolone—ulcerative colitis	0.000325	0.000451	CcSEcCtD
Duloxetine—Vomiting—Azathioprine—ulcerative colitis	0.000324	0.00045	CcSEcCtD
Duloxetine—Nervous system disorder—Hydrocortisone—ulcerative colitis	0.000324	0.00045	CcSEcCtD
Duloxetine—Myalgia—Methylprednisolone—ulcerative colitis	0.000324	0.00045	CcSEcCtD
Duloxetine—Arthralgia—Methylprednisolone—ulcerative colitis	0.000324	0.00045	CcSEcCtD
Duloxetine—Eye disorder—Prednisone—ulcerative colitis	0.000324	0.000449	CcSEcCtD
Duloxetine—Anxiety—Methylprednisolone—ulcerative colitis	0.000323	0.000448	CcSEcCtD
Duloxetine—Tachycardia—Hydrocortisone—ulcerative colitis	0.000323	0.000448	CcSEcCtD
Duloxetine—Rash—Azathioprine—ulcerative colitis	0.000322	0.000447	CcSEcCtD
Duloxetine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	0.000322	0.000447	CcSEcCtD
Duloxetine—Dermatitis—Azathioprine—ulcerative colitis	0.000321	0.000446	CcSEcCtD
Duloxetine—Flushing—Prednisone—ulcerative colitis	0.000321	0.000446	CcSEcCtD
Duloxetine—Skin disorder—Hydrocortisone—ulcerative colitis	0.000321	0.000446	CcSEcCtD
Duloxetine—Ill-defined disorder—Dexamethasone—ulcerative colitis	0.000321	0.000446	CcSEcCtD
Duloxetine—Ill-defined disorder—Betamethasone—ulcerative colitis	0.000321	0.000446	CcSEcCtD
Duloxetine—Discomfort—Triamcinolone—ulcerative colitis	0.000321	0.000445	CcSEcCtD
Duloxetine—Discomfort—Methylprednisolone—ulcerative colitis	0.00032	0.000444	CcSEcCtD
Duloxetine—Headache—Azathioprine—ulcerative colitis	0.00032	0.000444	CcSEcCtD
Duloxetine—Hyperhidrosis—Hydrocortisone—ulcerative colitis	0.00032	0.000444	CcSEcCtD
Duloxetine—Diarrhoea—Mesalazine—ulcerative colitis	0.000318	0.000442	CcSEcCtD
Duloxetine—Dry mouth—Triamcinolone—ulcerative colitis	0.000318	0.000441	CcSEcCtD
Duloxetine—Angioedema—Dexamethasone—ulcerative colitis	0.000316	0.000439	CcSEcCtD
Duloxetine—Angioedema—Betamethasone—ulcerative colitis	0.000316	0.000439	CcSEcCtD
Duloxetine—Anorexia—Hydrocortisone—ulcerative colitis	0.000315	0.000437	CcSEcCtD
Duloxetine—Angiopathy—Prednisone—ulcerative colitis	0.000314	0.000436	CcSEcCtD
Duloxetine—Confusional state—Methylprednisolone—ulcerative colitis	0.000313	0.000435	CcSEcCtD
Duloxetine—Immune system disorder—Prednisone—ulcerative colitis	0.000313	0.000434	CcSEcCtD
Duloxetine—Malaise—Betamethasone—ulcerative colitis	0.000312	0.000433	CcSEcCtD
Duloxetine—Malaise—Dexamethasone—ulcerative colitis	0.000312	0.000433	CcSEcCtD
Duloxetine—Anaphylactic shock—Triamcinolone—ulcerative colitis	0.000311	0.000432	CcSEcCtD
Duloxetine—Oedema—Triamcinolone—ulcerative colitis	0.000311	0.000432	CcSEcCtD
Duloxetine—Vertigo—Betamethasone—ulcerative colitis	0.000311	0.000432	CcSEcCtD
Duloxetine—Vertigo—Dexamethasone—ulcerative colitis	0.000311	0.000432	CcSEcCtD
Duloxetine—Anaphylactic shock—Methylprednisolone—ulcerative colitis	0.000311	0.000431	CcSEcCtD
Duloxetine—Syncope—Betamethasone—ulcerative colitis	0.00031	0.000431	CcSEcCtD
Duloxetine—Syncope—Dexamethasone—ulcerative colitis	0.00031	0.000431	CcSEcCtD
Duloxetine—Arrhythmia—Prednisone—ulcerative colitis	0.000309	0.000429	CcSEcCtD
Duloxetine—Infection—Triamcinolone—ulcerative colitis	0.000309	0.000429	CcSEcCtD
Duloxetine—Infection—Methylprednisolone—ulcerative colitis	0.000309	0.000428	CcSEcCtD
Duloxetine—Dizziness—Mesalazine—ulcerative colitis	0.000307	0.000427	CcSEcCtD
Duloxetine—Shock—Triamcinolone—ulcerative colitis	0.000306	0.000425	CcSEcCtD
Duloxetine—Insomnia—Prednisolone—ulcerative colitis	0.000306	0.000425	CcSEcCtD
Duloxetine—Alopecia—Prednisone—ulcerative colitis	0.000306	0.000425	CcSEcCtD
Duloxetine—Shock—Methylprednisolone—ulcerative colitis	0.000306	0.000424	CcSEcCtD
Duloxetine—Nervous system disorder—Methylprednisolone—ulcerative colitis	0.000305	0.000423	CcSEcCtD
Duloxetine—Loss of consciousness—Dexamethasone—ulcerative colitis	0.000304	0.000422	CcSEcCtD
Duloxetine—Loss of consciousness—Betamethasone—ulcerative colitis	0.000304	0.000422	CcSEcCtD
Duloxetine—Paraesthesia—Prednisolone—ulcerative colitis	0.000304	0.000422	CcSEcCtD
Duloxetine—Tachycardia—Triamcinolone—ulcerative colitis	0.000304	0.000422	CcSEcCtD
Duloxetine—Mental disorder—Prednisone—ulcerative colitis	0.000303	0.000421	CcSEcCtD
Duloxetine—Nausea—Azathioprine—ulcerative colitis	0.000303	0.000421	CcSEcCtD
Duloxetine—Tachycardia—Methylprednisolone—ulcerative colitis	0.000303	0.000421	CcSEcCtD
Duloxetine—Skin disorder—Methylprednisolone—ulcerative colitis	0.000302	0.000419	CcSEcCtD
Duloxetine—Erythema—Prednisone—ulcerative colitis	0.000301	0.000418	CcSEcCtD
Duloxetine—Malnutrition—Prednisone—ulcerative colitis	0.000301	0.000418	CcSEcCtD
Duloxetine—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	0.000301	0.000418	CcSEcCtD
Duloxetine—Hyperhidrosis—Triamcinolone—ulcerative colitis	0.000301	0.000418	CcSEcCtD
Duloxetine—Hyperhidrosis—Methylprednisolone—ulcerative colitis	0.0003	0.000417	CcSEcCtD
Duloxetine—Convulsion—Betamethasone—ulcerative colitis	0.0003	0.000416	CcSEcCtD
Duloxetine—Convulsion—Dexamethasone—ulcerative colitis	0.0003	0.000416	CcSEcCtD
Duloxetine—Insomnia—Hydrocortisone—ulcerative colitis	0.000299	0.000415	CcSEcCtD
Duloxetine—Hypertension—Dexamethasone—ulcerative colitis	0.000299	0.000415	CcSEcCtD
Duloxetine—Hypertension—Betamethasone—ulcerative colitis	0.000299	0.000415	CcSEcCtD
Duloxetine—Paraesthesia—Hydrocortisone—ulcerative colitis	0.000297	0.000412	CcSEcCtD
Duloxetine—Vomiting—Mesalazine—ulcerative colitis	0.000296	0.00041	CcSEcCtD
Duloxetine—Myalgia—Dexamethasone—ulcerative colitis	0.000295	0.000409	CcSEcCtD
Duloxetine—Myalgia—Betamethasone—ulcerative colitis	0.000295	0.000409	CcSEcCtD
Duloxetine—Anxiety—Betamethasone—ulcerative colitis	0.000294	0.000408	CcSEcCtD
Duloxetine—Anxiety—Dexamethasone—ulcerative colitis	0.000294	0.000408	CcSEcCtD
Duloxetine—Rash—Mesalazine—ulcerative colitis	0.000293	0.000407	CcSEcCtD
Duloxetine—Dermatitis—Mesalazine—ulcerative colitis	0.000293	0.000407	CcSEcCtD
Duloxetine—Headache—Mesalazine—ulcerative colitis	0.000291	0.000404	CcSEcCtD
Duloxetine—Discomfort—Betamethasone—ulcerative colitis	0.000291	0.000404	CcSEcCtD
Duloxetine—Discomfort—Dexamethasone—ulcerative colitis	0.000291	0.000404	CcSEcCtD
Duloxetine—Dyspepsia—Hydrocortisone—ulcerative colitis	0.000291	0.000404	CcSEcCtD
Duloxetine—Pain—Prednisolone—ulcerative colitis	0.000289	0.000402	CcSEcCtD
Duloxetine—Decreased appetite—Hydrocortisone—ulcerative colitis	0.000287	0.000399	CcSEcCtD
Duloxetine—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	0.000285	0.000396	CcSEcCtD
Duloxetine—Fatigue—Hydrocortisone—ulcerative colitis	0.000285	0.000396	CcSEcCtD
Duloxetine—Vision blurred—Prednisone—ulcerative colitis	0.000284	0.000394	CcSEcCtD
Duloxetine—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	0.000284	0.000394	CcSEcCtD
Duloxetine—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	0.000283	0.000393	CcSEcCtD
Duloxetine—Pain—Hydrocortisone—ulcerative colitis	0.000283	0.000392	CcSEcCtD
Duloxetine—Oedema—Betamethasone—ulcerative colitis	0.000282	0.000392	CcSEcCtD
Duloxetine—Anaphylactic shock—Betamethasone—ulcerative colitis	0.000282	0.000392	CcSEcCtD
Duloxetine—Anaphylactic shock—Dexamethasone—ulcerative colitis	0.000282	0.000392	CcSEcCtD
Duloxetine—Oedema—Dexamethasone—ulcerative colitis	0.000282	0.000392	CcSEcCtD
Duloxetine—Insomnia—Triamcinolone—ulcerative colitis	0.000282	0.000391	CcSEcCtD
Duloxetine—Insomnia—Methylprednisolone—ulcerative colitis	0.000281	0.00039	CcSEcCtD
Duloxetine—Infection—Dexamethasone—ulcerative colitis	0.000281	0.00039	CcSEcCtD
Duloxetine—Infection—Betamethasone—ulcerative colitis	0.000281	0.00039	CcSEcCtD
Duloxetine—Ill-defined disorder—Prednisone—ulcerative colitis	0.00028	0.000388	CcSEcCtD
Duloxetine—Paraesthesia—Triamcinolone—ulcerative colitis	0.000279	0.000388	CcSEcCtD
Duloxetine—Feeling abnormal—Prednisolone—ulcerative colitis	0.000279	0.000387	CcSEcCtD
Duloxetine—Paraesthesia—Methylprednisolone—ulcerative colitis	0.000279	0.000387	CcSEcCtD
Duloxetine—Anaemia—Prednisone—ulcerative colitis	0.000279	0.000387	CcSEcCtD
Duloxetine—Shock—Betamethasone—ulcerative colitis	0.000278	0.000386	CcSEcCtD
Duloxetine—Shock—Dexamethasone—ulcerative colitis	0.000278	0.000386	CcSEcCtD
Duloxetine—Nervous system disorder—Dexamethasone—ulcerative colitis	0.000277	0.000385	CcSEcCtD
Duloxetine—Nervous system disorder—Betamethasone—ulcerative colitis	0.000277	0.000385	CcSEcCtD
Duloxetine—Agitation—Prednisone—ulcerative colitis	0.000277	0.000384	CcSEcCtD
Duloxetine—Thrombocytopenia—Betamethasone—ulcerative colitis	0.000277	0.000384	CcSEcCtD
Duloxetine—Thrombocytopenia—Dexamethasone—ulcerative colitis	0.000277	0.000384	CcSEcCtD
Duloxetine—Nausea—Mesalazine—ulcerative colitis	0.000276	0.000383	CcSEcCtD
Duloxetine—Tachycardia—Dexamethasone—ulcerative colitis	0.000276	0.000383	CcSEcCtD
Duloxetine—Tachycardia—Betamethasone—ulcerative colitis	0.000276	0.000383	CcSEcCtD
Duloxetine—Angioedema—Prednisone—ulcerative colitis	0.000275	0.000382	CcSEcCtD
Duloxetine—Dyspepsia—Triamcinolone—ulcerative colitis	0.000274	0.00038	CcSEcCtD
Duloxetine—Dyspepsia—Methylprednisolone—ulcerative colitis	0.000273	0.00038	CcSEcCtD
Duloxetine—Hyperhidrosis—Dexamethasone—ulcerative colitis	0.000273	0.000379	CcSEcCtD
Duloxetine—Hyperhidrosis—Betamethasone—ulcerative colitis	0.000273	0.000379	CcSEcCtD
Duloxetine—Feeling abnormal—Hydrocortisone—ulcerative colitis	0.000272	0.000378	CcSEcCtD
Duloxetine—Malaise—Prednisone—ulcerative colitis	0.000272	0.000377	CcSEcCtD
Duloxetine—Vertigo—Prednisone—ulcerative colitis	0.000271	0.000376	CcSEcCtD
Duloxetine—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	0.00027	0.000375	CcSEcCtD
Duloxetine—Syncope—Prednisone—ulcerative colitis	0.00027	0.000375	CcSEcCtD
Duloxetine—Anorexia—Betamethasone—ulcerative colitis	0.000269	0.000374	CcSEcCtD
Duloxetine—Anorexia—Dexamethasone—ulcerative colitis	0.000269	0.000374	CcSEcCtD
Duloxetine—Urticaria—Prednisolone—ulcerative colitis	0.000269	0.000373	CcSEcCtD
Duloxetine—Fatigue—Triamcinolone—ulcerative colitis	0.000268	0.000373	CcSEcCtD
Duloxetine—Fatigue—Methylprednisolone—ulcerative colitis	0.000268	0.000372	CcSEcCtD
Duloxetine—Pain—Triamcinolone—ulcerative colitis	0.000266	0.00037	CcSEcCtD
Duloxetine—Loss of consciousness—Prednisone—ulcerative colitis	0.000265	0.000368	CcSEcCtD
Duloxetine—Urticaria—Hydrocortisone—ulcerative colitis	0.000263	0.000365	CcSEcCtD
Duloxetine—Abdominal pain—Hydrocortisone—ulcerative colitis	0.000261	0.000363	CcSEcCtD
Duloxetine—Body temperature increased—Hydrocortisone—ulcerative colitis	0.000261	0.000363	CcSEcCtD
Duloxetine—Convulsion—Prednisone—ulcerative colitis	0.000261	0.000362	CcSEcCtD
Duloxetine—Hypertension—Prednisone—ulcerative colitis	0.00026	0.000361	CcSEcCtD
Duloxetine—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	0.000257	0.000357	CcSEcCtD
Duloxetine—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	0.000257	0.000357	CcSEcCtD
Duloxetine—Arthralgia—Prednisone—ulcerative colitis	0.000257	0.000356	CcSEcCtD
Duloxetine—Myalgia—Prednisone—ulcerative colitis	0.000257	0.000356	CcSEcCtD
Duloxetine—Feeling abnormal—Triamcinolone—ulcerative colitis	0.000256	0.000356	CcSEcCtD
Duloxetine—Feeling abnormal—Methylprednisolone—ulcerative colitis	0.000256	0.000355	CcSEcCtD
Duloxetine—Anxiety—Prednisone—ulcerative colitis	0.000256	0.000355	CcSEcCtD
Duloxetine—Insomnia—Dexamethasone—ulcerative colitis	0.000255	0.000355	CcSEcCtD
Duloxetine—Insomnia—Betamethasone—ulcerative colitis	0.000255	0.000355	CcSEcCtD
Duloxetine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	0.000255	0.000354	CcSEcCtD
Duloxetine—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	0.000254	0.000353	CcSEcCtD
Duloxetine—Paraesthesia—Betamethasone—ulcerative colitis	0.000254	0.000352	CcSEcCtD
Duloxetine—Paraesthesia—Dexamethasone—ulcerative colitis	0.000254	0.000352	CcSEcCtD
Duloxetine—Discomfort—Prednisone—ulcerative colitis	0.000253	0.000352	CcSEcCtD
Duloxetine—HTR2C—GPCR ligand binding—CCR6—ulcerative colitis	0.000252	0.00128	CbGpPWpGaD
Duloxetine—Hypersensitivity—Prednisolone—ulcerative colitis	0.000249	0.000346	CcSEcCtD
Duloxetine—Dyspepsia—Dexamethasone—ulcerative colitis	0.000249	0.000345	CcSEcCtD
Duloxetine—Dyspepsia—Betamethasone—ulcerative colitis	0.000249	0.000345	CcSEcCtD
Duloxetine—Urticaria—Triamcinolone—ulcerative colitis	0.000247	0.000343	CcSEcCtD
Duloxetine—NPY1R—Signaling Pathways—PTGER4—ulcerative colitis	0.000247	0.00126	CbGpPWpGaD
Duloxetine—Urticaria—Methylprednisolone—ulcerative colitis	0.000247	0.000343	CcSEcCtD
Duloxetine—Body temperature increased—Triamcinolone—ulcerative colitis	0.000246	0.000342	CcSEcCtD
Duloxetine—Anaphylactic shock—Prednisone—ulcerative colitis	0.000246	0.000341	CcSEcCtD
Duloxetine—Oedema—Prednisone—ulcerative colitis	0.000246	0.000341	CcSEcCtD
Duloxetine—Abdominal pain—Methylprednisolone—ulcerative colitis	0.000246	0.000341	CcSEcCtD
Duloxetine—Decreased appetite—Dexamethasone—ulcerative colitis	0.000246	0.000341	CcSEcCtD
Duloxetine—Decreased appetite—Betamethasone—ulcerative colitis	0.000246	0.000341	CcSEcCtD
Duloxetine—Infection—Prednisone—ulcerative colitis	0.000244	0.000339	CcSEcCtD
Duloxetine—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	0.000244	0.000339	CcSEcCtD
Duloxetine—Gastrointestinal disorder—Betamethasone—ulcerative colitis	0.000244	0.000339	CcSEcCtD
Duloxetine—Hypersensitivity—Hydrocortisone—ulcerative colitis	0.000244	0.000338	CcSEcCtD
Duloxetine—Fatigue—Dexamethasone—ulcerative colitis	0.000243	0.000338	CcSEcCtD
Duloxetine—Fatigue—Betamethasone—ulcerative colitis	0.000243	0.000338	CcSEcCtD
Duloxetine—Shock—Prednisone—ulcerative colitis	0.000242	0.000336	CcSEcCtD
Duloxetine—Pain—Dexamethasone—ulcerative colitis	0.000242	0.000335	CcSEcCtD
Duloxetine—Pain—Betamethasone—ulcerative colitis	0.000242	0.000335	CcSEcCtD
Duloxetine—Nervous system disorder—Prednisone—ulcerative colitis	0.000241	0.000335	CcSEcCtD
Duloxetine—Tachycardia—Prednisone—ulcerative colitis	0.00024	0.000333	CcSEcCtD
Duloxetine—SLC6A4—SIDS Susceptibility Pathways—NFKB1—ulcerative colitis	0.00024	0.00122	CbGpPWpGaD
Duloxetine—Skin disorder—Prednisone—ulcerative colitis	0.000239	0.000332	CcSEcCtD
Duloxetine—HTR6—Signaling by GPCR—CXCR1—ulcerative colitis	0.000238	0.00122	CbGpPWpGaD
Duloxetine—CYP2D6—Biological oxidations—PTGS1—ulcerative colitis	0.000238	0.00122	CbGpPWpGaD
Duloxetine—Hyperhidrosis—Prednisone—ulcerative colitis	0.000238	0.00033	CcSEcCtD
Duloxetine—Asthenia—Hydrocortisone—ulcerative colitis	0.000237	0.000329	CcSEcCtD
Duloxetine—Anorexia—Prednisone—ulcerative colitis	0.000234	0.000325	CcSEcCtD
Duloxetine—Pruritus—Hydrocortisone—ulcerative colitis	0.000234	0.000325	CcSEcCtD
Duloxetine—Feeling abnormal—Dexamethasone—ulcerative colitis	0.000233	0.000323	CcSEcCtD
Duloxetine—Feeling abnormal—Betamethasone—ulcerative colitis	0.000233	0.000323	CcSEcCtD
Duloxetine—HTR2A—GPCR ligand binding—CXCR2—ulcerative colitis	0.000232	0.00119	CbGpPWpGaD
Duloxetine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—ulcerative colitis	0.000232	0.00118	CbGpPWpGaD
Duloxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	0.000231	0.00118	CbGpPWpGaD
Duloxetine—Gastrointestinal pain—Betamethasone—ulcerative colitis	0.000231	0.000321	CcSEcCtD
Duloxetine—Gastrointestinal pain—Dexamethasone—ulcerative colitis	0.000231	0.000321	CcSEcCtD
Duloxetine—HTR6—GPCR downstream signaling—CCL20—ulcerative colitis	0.00023	0.00118	CbGpPWpGaD
Duloxetine—Hypersensitivity—Triamcinolone—ulcerative colitis	0.000229	0.000318	CcSEcCtD
Duloxetine—Hypersensitivity—Methylprednisolone—ulcerative colitis	0.000229	0.000318	CcSEcCtD
Duloxetine—CYP1A2—Aryl Hydrocarbon Receptor—RELA—ulcerative colitis	0.000228	0.00117	CbGpPWpGaD
Duloxetine—HTR6—GPCR ligand binding—ADRB2—ulcerative colitis	0.000228	0.00116	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—GHRL—ulcerative colitis	0.000226	0.00116	CbGpPWpGaD
Duloxetine—Diarrhoea—Hydrocortisone—ulcerative colitis	0.000226	0.000314	CcSEcCtD
Duloxetine—SLC6A3—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	0.000226	0.00115	CbGpPWpGaD
Duloxetine—SLC6A3—Neuronal System—ADCY5—ulcerative colitis	0.000225	0.00115	CbGpPWpGaD
Duloxetine—Urticaria—Dexamethasone—ulcerative colitis	0.000224	0.000311	CcSEcCtD
Duloxetine—Urticaria—Betamethasone—ulcerative colitis	0.000224	0.000311	CcSEcCtD
Duloxetine—Musculoskeletal discomfort—Prednisone—ulcerative colitis	0.000224	0.000311	CcSEcCtD
Duloxetine—Dizziness—Prednisolone—ulcerative colitis	0.000224	0.000311	CcSEcCtD
Duloxetine—HTR2A—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	0.000223	0.00114	CbGpPWpGaD
Duloxetine—Asthenia—Triamcinolone—ulcerative colitis	0.000223	0.00031	CcSEcCtD
Duloxetine—Body temperature increased—Betamethasone—ulcerative colitis	0.000223	0.00031	CcSEcCtD
Duloxetine—Abdominal pain—Dexamethasone—ulcerative colitis	0.000223	0.00031	CcSEcCtD
Duloxetine—Body temperature increased—Dexamethasone—ulcerative colitis	0.000223	0.00031	CcSEcCtD
Duloxetine—Abdominal pain—Betamethasone—ulcerative colitis	0.000223	0.00031	CcSEcCtD
Duloxetine—Asthenia—Methylprednisolone—ulcerative colitis	0.000223	0.000309	CcSEcCtD
Duloxetine—Insomnia—Prednisone—ulcerative colitis	0.000222	0.000309	CcSEcCtD
Duloxetine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—ulcerative colitis	0.000222	0.00113	CbGpPWpGaD
Duloxetine—HTR2C—GPCR ligand binding—PTGER4—ulcerative colitis	0.000221	0.00113	CbGpPWpGaD
Duloxetine—Paraesthesia—Prednisone—ulcerative colitis	0.000221	0.000307	CcSEcCtD
Duloxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	0.00022	0.00113	CbGpPWpGaD
Duloxetine—Pruritus—Triamcinolone—ulcerative colitis	0.00022	0.000306	CcSEcCtD
Duloxetine—Pruritus—Methylprednisolone—ulcerative colitis	0.00022	0.000305	CcSEcCtD
Duloxetine—NPY1R—Signaling Pathways—CALM3—ulcerative colitis	0.000219	0.00112	CbGpPWpGaD
Duloxetine—Dizziness—Hydrocortisone—ulcerative colitis	0.000219	0.000303	CcSEcCtD
Duloxetine—HTR2A—GPCR ligand binding—CCR6—ulcerative colitis	0.000218	0.00112	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—GNA12—ulcerative colitis	0.000217	0.00111	CbGpPWpGaD
Duloxetine—Dyspepsia—Prednisone—ulcerative colitis	0.000216	0.000301	CcSEcCtD
Duloxetine—NPY1R—Signaling Pathways—RIPK2—ulcerative colitis	0.000216	0.0011	CbGpPWpGaD
Duloxetine—Decreased appetite—Prednisone—ulcerative colitis	0.000214	0.000297	CcSEcCtD
Duloxetine—Rash—Prednisolone—ulcerative colitis	0.000213	0.000296	CcSEcCtD
Duloxetine—Dermatitis—Prednisolone—ulcerative colitis	0.000213	0.000296	CcSEcCtD
Duloxetine—Diarrhoea—Methylprednisolone—ulcerative colitis	0.000212	0.000295	CcSEcCtD
Duloxetine—Fatigue—Prednisone—ulcerative colitis	0.000212	0.000294	CcSEcCtD
Duloxetine—Headache—Prednisolone—ulcerative colitis	0.000212	0.000294	CcSEcCtD
Duloxetine—SLC6A4—NRF2 pathway—TGFB1—ulcerative colitis	0.000211	0.00108	CbGpPWpGaD
Duloxetine—Constipation—Prednisone—ulcerative colitis	0.00021	0.000292	CcSEcCtD
Duloxetine—Vomiting—Hydrocortisone—ulcerative colitis	0.00021	0.000292	CcSEcCtD
Duloxetine—HTR6—Signaling by GPCR—CCL20—ulcerative colitis	0.000209	0.00107	CbGpPWpGaD
Duloxetine—Rash—Hydrocortisone—ulcerative colitis	0.000208	0.000289	CcSEcCtD
Duloxetine—Dermatitis—Hydrocortisone—ulcerative colitis	0.000208	0.000289	CcSEcCtD
Duloxetine—CYP1A2—Arachidonic acid metabolism—PTGS2—ulcerative colitis	0.000208	0.00106	CbGpPWpGaD
Duloxetine—Headache—Hydrocortisone—ulcerative colitis	0.000207	0.000287	CcSEcCtD
Duloxetine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—ulcerative colitis	0.000207	0.00105	CbGpPWpGaD
Duloxetine—Dizziness—Triamcinolone—ulcerative colitis	0.000206	0.000286	CcSEcCtD
Duloxetine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—ulcerative colitis	0.000206	0.00105	CbGpPWpGaD
Duloxetine—Dizziness—Methylprednisolone—ulcerative colitis	0.000205	0.000285	CcSEcCtD
Duloxetine—HTR6—GPCR downstream signaling—CXCR2—ulcerative colitis	0.000205	0.00105	CbGpPWpGaD
Duloxetine—HTR2C—GPCR ligand binding—GHRL—ulcerative colitis	0.000203	0.00104	CbGpPWpGaD
Duloxetine—Feeling abnormal—Prednisone—ulcerative colitis	0.000203	0.000281	CcSEcCtD
Duloxetine—Asthenia—Dexamethasone—ulcerative colitis	0.000203	0.000281	CcSEcCtD
Duloxetine—Asthenia—Betamethasone—ulcerative colitis	0.000203	0.000281	CcSEcCtD
Duloxetine—CYP1A2—Biological oxidations—PTGS1—ulcerative colitis	0.000202	0.00103	CbGpPWpGaD
Duloxetine—Gastrointestinal pain—Prednisone—ulcerative colitis	0.000201	0.000279	CcSEcCtD
Duloxetine—Nausea—Prednisolone—ulcerative colitis	0.000201	0.000279	CcSEcCtD
Duloxetine—Pruritus—Betamethasone—ulcerative colitis	0.0002	0.000277	CcSEcCtD
Duloxetine—Pruritus—Dexamethasone—ulcerative colitis	0.0002	0.000277	CcSEcCtD
Duloxetine—Vomiting—Triamcinolone—ulcerative colitis	0.000198	0.000275	CcSEcCtD
Duloxetine—Vomiting—Methylprednisolone—ulcerative colitis	0.000197	0.000274	CcSEcCtD
Duloxetine—HTR6—Signaling by GPCR—GNA12—ulcerative colitis	0.000197	0.001	CbGpPWpGaD
Duloxetine—Nausea—Hydrocortisone—ulcerative colitis	0.000196	0.000273	CcSEcCtD
Duloxetine—Rash—Triamcinolone—ulcerative colitis	0.000196	0.000272	CcSEcCtD
Duloxetine—Dermatitis—Triamcinolone—ulcerative colitis	0.000196	0.000272	CcSEcCtD
Duloxetine—Rash—Methylprednisolone—ulcerative colitis	0.000196	0.000272	CcSEcCtD
Duloxetine—Dermatitis—Methylprednisolone—ulcerative colitis	0.000196	0.000272	CcSEcCtD
Duloxetine—Urticaria—Prednisone—ulcerative colitis	0.000195	0.000271	CcSEcCtD
Duloxetine—Headache—Triamcinolone—ulcerative colitis	0.000195	0.000271	CcSEcCtD
Duloxetine—Headache—Methylprednisolone—ulcerative colitis	0.000195	0.00027	CcSEcCtD
Duloxetine—Body temperature increased—Prednisone—ulcerative colitis	0.000194	0.00027	CcSEcCtD
Duloxetine—Abdominal pain—Prednisone—ulcerative colitis	0.000194	0.00027	CcSEcCtD
Duloxetine—HTR2C—GPCR downstream signaling—CXCR1—ulcerative colitis	0.000193	0.000987	CbGpPWpGaD
Duloxetine—Diarrhoea—Betamethasone—ulcerative colitis	0.000193	0.000268	CcSEcCtD
Duloxetine—Diarrhoea—Dexamethasone—ulcerative colitis	0.000193	0.000268	CcSEcCtD
Duloxetine—HTR6—GPCR downstream signaling—CCR6—ulcerative colitis	0.000193	0.000986	CbGpPWpGaD
Duloxetine—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—ulcerative colitis	0.000193	0.000984	CbGpPWpGaD
Duloxetine—HTR2A—GPCR ligand binding—PTGER4—ulcerative colitis	0.000192	0.000982	CbGpPWpGaD
Duloxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	0.000191	0.000977	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—ADRB2—ulcerative colitis	0.000187	0.000956	CbGpPWpGaD
Duloxetine—Dizziness—Dexamethasone—ulcerative colitis	0.000187	0.000259	CcSEcCtD
Duloxetine—Dizziness—Betamethasone—ulcerative colitis	0.000187	0.000259	CcSEcCtD
Duloxetine—SLC6A4—SIDS Susceptibility Pathways—TNF—ulcerative colitis	0.000187	0.000953	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—CXCR2—ulcerative colitis	0.000186	0.000952	CbGpPWpGaD
Duloxetine—Nausea—Triamcinolone—ulcerative colitis	0.000185	0.000257	CcSEcCtD
Duloxetine—NPY1R—GPCR downstream signaling—JAK2—ulcerative colitis	0.000185	0.000943	CbGpPWpGaD
Duloxetine—Nausea—Methylprednisolone—ulcerative colitis	0.000184	0.000256	CcSEcCtD
Duloxetine—SLC6A2—NRF2 pathway—TGFB1—ulcerative colitis	0.000181	0.000925	CbGpPWpGaD
Duloxetine—Hypersensitivity—Prednisone—ulcerative colitis	0.000181	0.000252	CcSEcCtD
Duloxetine—SLC6A2—SLC-mediated transmembrane transport—ALB—ulcerative colitis	0.000181	0.000922	CbGpPWpGaD
Duloxetine—Vomiting—Dexamethasone—ulcerative colitis	0.00018	0.000249	CcSEcCtD
Duloxetine—Vomiting—Betamethasone—ulcerative colitis	0.00018	0.000249	CcSEcCtD
Duloxetine—Rash—Betamethasone—ulcerative colitis	0.000178	0.000247	CcSEcCtD
Duloxetine—Rash—Dexamethasone—ulcerative colitis	0.000178	0.000247	CcSEcCtD
Duloxetine—Dermatitis—Betamethasone—ulcerative colitis	0.000178	0.000247	CcSEcCtD
Duloxetine—Dermatitis—Dexamethasone—ulcerative colitis	0.000178	0.000247	CcSEcCtD
Duloxetine—Headache—Dexamethasone—ulcerative colitis	0.000177	0.000246	CcSEcCtD
Duloxetine—Headache—Betamethasone—ulcerative colitis	0.000177	0.000246	CcSEcCtD
Duloxetine—Asthenia—Prednisone—ulcerative colitis	0.000176	0.000245	CcSEcCtD
Duloxetine—HTR2A—GPCR ligand binding—GHRL—ulcerative colitis	0.000176	0.000899	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—CXCR1—ulcerative colitis	0.000175	0.000896	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—CCR6—ulcerative colitis	0.000175	0.000895	CbGpPWpGaD
Duloxetine—Pruritus—Prednisone—ulcerative colitis	0.000174	0.000242	CcSEcCtD
Duloxetine—HTR6—Signaling Pathways—SEL1L—ulcerative colitis	0.000171	0.000873	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—PTGER4—ulcerative colitis	0.00017	0.000868	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—CCL20—ulcerative colitis	0.00017	0.000866	CbGpPWpGaD
Duloxetine—NPY1R—GPCR downstream signaling—CXCL8—ulcerative colitis	0.000169	0.000861	CbGpPWpGaD
Duloxetine—Diarrhoea—Prednisone—ulcerative colitis	0.000168	0.000234	CcSEcCtD
Duloxetine—HTR2C—GPCR ligand binding—ADRB2—ulcerative colitis	0.000168	0.000857	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—CXCR1—ulcerative colitis	0.000168	0.000857	CbGpPWpGaD
Duloxetine—NPY1R—Signaling by GPCR—JAK2—ulcerative colitis	0.000168	0.000857	CbGpPWpGaD
Duloxetine—Nausea—Dexamethasone—ulcerative colitis	0.000168	0.000233	CcSEcCtD
Duloxetine—Nausea—Betamethasone—ulcerative colitis	0.000168	0.000233	CcSEcCtD
Duloxetine—Dizziness—Prednisone—ulcerative colitis	0.000163	0.000226	CcSEcCtD
Duloxetine—HTR2A—SIDS Susceptibility Pathways—CXCL8—ulcerative colitis	0.000161	0.000824	CbGpPWpGaD
Duloxetine—NPY1R—GPCR downstream signaling—IL2—ulcerative colitis	0.000161	0.000823	CbGpPWpGaD
Duloxetine—SLC6A3—NRF2 pathway—TGFB1—ulcerative colitis	0.000161	0.00082	CbGpPWpGaD
Duloxetine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—ulcerative colitis	0.00016	0.000819	CbGpPWpGaD
Duloxetine—SLC6A3—SLC-mediated transmembrane transport—ALB—ulcerative colitis	0.00016	0.000817	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—GNA12—ulcerative colitis	0.00016	0.000814	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—ADCY5—ulcerative colitis	0.000159	0.000812	CbGpPWpGaD
Duloxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—ulcerative colitis	0.000158	0.000804	CbGpPWpGaD
Duloxetine—Vomiting—Prednisone—ulcerative colitis	0.000156	0.000217	CcSEcCtD
Duloxetine—HTR6—GPCR downstream signaling—GHRL—ulcerative colitis	0.000156	0.000794	CbGpPWpGaD
Duloxetine—Rash—Prednisone—ulcerative colitis	0.000155	0.000215	CcSEcCtD
Duloxetine—Dermatitis—Prednisone—ulcerative colitis	0.000155	0.000215	CcSEcCtD
Duloxetine—HTR2A—SIDS Susceptibility Pathways—IL1B—ulcerative colitis	0.000155	0.00079	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—PTGER4—ulcerative colitis	0.000154	0.000788	CbGpPWpGaD
Duloxetine—Headache—Prednisone—ulcerative colitis	0.000154	0.000214	CcSEcCtD
Duloxetine—HTR2C—Signaling by GPCR—CCL20—ulcerative colitis	0.000154	0.000787	CbGpPWpGaD
Duloxetine—NPY1R—Signaling by GPCR—CXCL8—ulcerative colitis	0.000153	0.000782	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—CXCR1—ulcerative colitis	0.000152	0.000778	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—CXCR2—ulcerative colitis	0.000151	0.000772	CbGpPWpGaD
Duloxetine—SLC6A4—SIDS Susceptibility Pathways—IL6—ulcerative colitis	0.000151	0.000769	CbGpPWpGaD
Duloxetine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—ulcerative colitis	0.00015	0.000765	CbGpPWpGaD
Duloxetine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—ulcerative colitis	0.00015	0.000765	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—CCL20—ulcerative colitis	0.000147	0.000752	CbGpPWpGaD
Duloxetine—SLC6A2—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	0.000147	0.000749	CbGpPWpGaD
Duloxetine—NPY1R—Signaling by GPCR—IL2—ulcerative colitis	0.000146	0.000747	CbGpPWpGaD
Duloxetine—Nausea—Prednisone—ulcerative colitis	0.000146	0.000203	CcSEcCtD
Duloxetine—HTR2A—GPCR ligand binding—ADRB2—ulcerative colitis	0.000146	0.000744	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—GNA12—ulcerative colitis	0.000145	0.00074	CbGpPWpGaD
Duloxetine—HTR6—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	0.000145	0.000738	CbGpPWpGaD
Duloxetine—HTR2A—SIDS Susceptibility Pathways—NFKB1—ulcerative colitis	0.000144	0.000737	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—CCR6—ulcerative colitis	0.000142	0.000726	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—GHRL—ulcerative colitis	0.000141	0.000721	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CXCR1—ulcerative colitis	0.000141	0.000719	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—GNA12—ulcerative colitis	0.000139	0.000707	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—CXCR2—ulcerative colitis	0.000137	0.000701	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—CALM3—ulcerative colitis	0.000137	0.000699	CbGpPWpGaD
Duloxetine—SLC6A2—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	0.000137	0.000699	CbGpPWpGaD
Duloxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—ulcerative colitis	0.000137	0.000698	CbGpPWpGaD
Duloxetine—SLC6A4—Circadian rythm related genes—TP53—ulcerative colitis	0.000134	0.000686	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—CCL20—ulcerative colitis	0.000134	0.000683	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—CXCR2—ulcerative colitis	0.000131	0.00067	CbGpPWpGaD
Duloxetine—SLC6A3—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	0.00013	0.000663	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—CCR6—ulcerative colitis	0.000129	0.000659	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—ADRB2—ulcerative colitis	0.000129	0.000658	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—SEL1L—ulcerative colitis	0.000126	0.000643	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—GNA12—ulcerative colitis	0.000126	0.000642	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—PTGER4—ulcerative colitis	0.000125	0.000639	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CCL20—ulcerative colitis	0.000124	0.000631	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—CCR6—ulcerative colitis	0.000123	0.00063	CbGpPWpGaD
Duloxetine—SLC6A4—Circadian rythm related genes—IL6—ulcerative colitis	0.000123	0.000628	CbGpPWpGaD
Duloxetine—SLC6A3—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	0.000121	0.000619	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—CXCR2—ulcerative colitis	0.000119	0.000609	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—ADRB2—ulcerative colitis	0.000117	0.000597	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—GNA12—ulcerative colitis	0.000116	0.000593	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—GHRL—ulcerative colitis	0.000115	0.000585	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—PTGER4—ulcerative colitis	0.000114	0.00058	CbGpPWpGaD
Duloxetine—HTR2A—SIDS Susceptibility Pathways—TNF—ulcerative colitis	0.000112	0.000573	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—CCR6—ulcerative colitis	0.000112	0.000572	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CXCR2—ulcerative colitis	0.00011	0.000562	CbGpPWpGaD
Duloxetine—HTR6—GPCR ligand binding—CXCL8—ulcerative colitis	0.00011	0.000562	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—ADCY5—ulcerative colitis	0.000109	0.000558	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—SEL1L—ulcerative colitis	0.000109	0.000558	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—PTGER4—ulcerative colitis	0.000109	0.000555	CbGpPWpGaD
Duloxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	0.000106	0.000544	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—GHRL—ulcerative colitis	0.000104	0.000531	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CXCR1—ulcerative colitis	0.000104	0.000529	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CCR6—ulcerative colitis	0.000104	0.000529	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—CALM3—ulcerative colitis	0.000101	0.000515	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—GHRL—ulcerative colitis	9.95e-05	0.000508	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—ADCY5—ulcerative colitis	9.93e-05	0.000507	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—JAK2—ulcerative colitis	9.91e-05	0.000506	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—PTGER4—ulcerative colitis	9.87e-05	0.000504	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—MAML2—ulcerative colitis	9.82e-05	0.000501	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—CHP1—ulcerative colitis	9.76e-05	0.000498	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—RELA—ulcerative colitis	9.6e-05	0.00049	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—ADRB2—ulcerative colitis	9.49e-05	0.000484	CbGpPWpGaD
Duloxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	9.25e-05	0.000472	CbGpPWpGaD
Duloxetine—SLC6A2—Transmembrane transport of small molecules—ALB—ulcerative colitis	9.18e-05	0.000468	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—PTGER4—ulcerative colitis	9.12e-05	0.000466	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CCL20—ulcerative colitis	9.1e-05	0.000465	CbGpPWpGaD
Duloxetine—HTR2A—SIDS Susceptibility Pathways—IL6—ulcerative colitis	9.07e-05	0.000463	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—CXCL8—ulcerative colitis	9.05e-05	0.000462	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—GHRL—ulcerative colitis	9.04e-05	0.000461	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CXCR1—ulcerative colitis	9e-05	0.00046	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—CALM3—ulcerative colitis	8.75e-05	0.000447	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—IL2—ulcerative colitis	8.65e-05	0.000441	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—ADRB2—ulcerative colitis	8.61e-05	0.00044	CbGpPWpGaD
Duloxetine—NPY1R—Signaling by GPCR—IL6—ulcerative colitis	8.6e-05	0.000439	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—GNA12—ulcerative colitis	8.56e-05	0.000437	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—DLD—ulcerative colitis	8.42e-05	0.00043	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—GHRL—ulcerative colitis	8.35e-05	0.000426	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—CHP1—ulcerative colitis	8.27e-05	0.000422	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—ADRB2—ulcerative colitis	8.24e-05	0.000421	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—MMP9—ulcerative colitis	8.18e-05	0.000418	CbGpPWpGaD
Duloxetine—SLC6A3—Transmembrane transport of small molecules—ALB—ulcerative colitis	8.13e-05	0.000415	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CXCR2—ulcerative colitis	8.11e-05	0.000414	CbGpPWpGaD
Duloxetine—HTR2C—GPCR ligand binding—CXCL8—ulcerative colitis	8.11e-05	0.000414	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—NFKB1—ulcerative colitis	8.1e-05	0.000413	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CALM3—ulcerative colitis	8.09e-05	0.000413	CbGpPWpGaD
Duloxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	8.08e-05	0.000412	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—ADCY5—ulcerative colitis	8.05e-05	0.000411	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—RIPK2—ulcerative colitis	7.96e-05	0.000407	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CCL20—ulcerative colitis	7.9e-05	0.000403	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	7.74e-05	0.000395	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CCR6—ulcerative colitis	7.63e-05	0.000389	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—ADRB2—ulcerative colitis	7.48e-05	0.000382	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—GNA12—ulcerative colitis	7.43e-05	0.000379	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—ADCY5—ulcerative colitis	7.31e-05	0.000373	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—STAT3—ulcerative colitis	7.28e-05	0.000371	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—MAML2—ulcerative colitis	7.23e-05	0.000369	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—DLD—ulcerative colitis	7.13e-05	0.000364	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CXCR2—ulcerative colitis	7.04e-05	0.00036	CbGpPWpGaD
Duloxetine—HTR2A—GPCR ligand binding—CXCL8—ulcerative colitis	7.04e-05	0.000359	CbGpPWpGaD
Duloxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	7.01e-05	0.000358	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—ADCY5—ulcerative colitis	6.99e-05	0.000357	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—ADRB2—ulcerative colitis	6.91e-05	0.000353	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—JAK2—ulcerative colitis	6.82e-05	0.000348	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—TGFB1—ulcerative colitis	6.74e-05	0.000344	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—PTGER4—ulcerative colitis	6.71e-05	0.000343	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CCR6—ulcerative colitis	6.62e-05	0.000338	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—ADCY5—ulcerative colitis	6.35e-05	0.000324	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—MAML2—ulcerative colitis	6.28e-05	0.000321	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—CXCL8—ulcerative colitis	6.22e-05	0.000318	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—JAK2—ulcerative colitis	6.19e-05	0.000316	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—GHRL—ulcerative colitis	6.15e-05	0.000314	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CALM3—ulcerative colitis	5.95e-05	0.000304	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—IL2—ulcerative colitis	5.95e-05	0.000304	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—ADCY5—ulcerative colitis	5.87e-05	0.000299	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—RIPK2—ulcerative colitis	5.86e-05	0.000299	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—PTGER4—ulcerative colitis	5.83e-05	0.000298	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—CXCL8—ulcerative colitis	5.65e-05	0.000288	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—TP53—ulcerative colitis	5.55e-05	0.000283	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—IL2—ulcerative colitis	5.4e-05	0.000276	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—GHRL—ulcerative colitis	5.34e-05	0.000273	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CALM3—ulcerative colitis	5.17e-05	0.000264	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—RIPK2—ulcerative colitis	5.09e-05	0.00026	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—ADRB2—ulcerative colitis	5.09e-05	0.00026	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—IL6—ulcerative colitis	5.08e-05	0.000259	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—JAK2—ulcerative colitis	5.02e-05	0.000256	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—CXCL8—ulcerative colitis	4.58e-05	0.000234	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—JAK2—ulcerative colitis	4.56e-05	0.000233	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—ADRB2—ulcerative colitis	4.42e-05	0.000226	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—IL2—ulcerative colitis	4.38e-05	0.000224	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—JAK2—ulcerative colitis	4.36e-05	0.000223	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—ADCY5—ulcerative colitis	4.32e-05	0.000221	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—CXCL8—ulcerative colitis	4.16e-05	0.000212	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—PTGS1—ulcerative colitis	4.07e-05	0.000208	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—CXCL8—ulcerative colitis	3.98e-05	0.000203	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—IL2—ulcerative colitis	3.98e-05	0.000203	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—JAK2—ulcerative colitis	3.96e-05	0.000202	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—IL2—ulcerative colitis	3.8e-05	0.000194	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	3.77e-05	0.000193	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—ADCY5—ulcerative colitis	3.75e-05	0.000191	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—CALM3—ulcerative colitis	3.67e-05	0.000187	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—JAK2—ulcerative colitis	3.66e-05	0.000187	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—CXCL8—ulcerative colitis	3.61e-05	0.000184	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—RELA—ulcerative colitis	3.54e-05	0.000181	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—IL2—ulcerative colitis	3.45e-05	0.000176	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—PTGS1—ulcerative colitis	3.45e-05	0.000176	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	3.39e-05	0.000173	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CXCL8—ulcerative colitis	3.34e-05	0.00017	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—IL2—ulcerative colitis	3.19e-05	0.000163	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—IL6—ulcerative colitis	3.17e-05	0.000162	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—CALM3—ulcerative colitis	3.11e-05	0.000159	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—MMP9—ulcerative colitis	3.02e-05	0.000154	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—NFKB1—ulcerative colitis	2.99e-05	0.000152	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	2.97e-05	0.000152	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—ABCB1—ulcerative colitis	2.85e-05	0.000146	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—JAK2—ulcerative colitis	2.69e-05	0.000137	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—STAT3—ulcerative colitis	2.68e-05	0.000137	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—ADCY5—ulcerative colitis	2.66e-05	0.000136	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—RELA—ulcerative colitis	2.61e-05	0.000133	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—TGFB1—ulcerative colitis	2.49e-05	0.000127	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CXCL8—ulcerative colitis	2.46e-05	0.000125	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—ABCB1—ulcerative colitis	2.42e-05	0.000123	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—IL2—ulcerative colitis	2.35e-05	0.00012	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—JAK2—ulcerative colitis	2.34e-05	0.000119	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—IL6—ulcerative colitis	2.34e-05	0.000119	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—RELA—ulcerative colitis	2.26e-05	0.000116	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—ADCY5—ulcerative colitis	2.25e-05	0.000115	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—MMP9—ulcerative colitis	2.22e-05	0.000113	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—NFKB1—ulcerative colitis	2.2e-05	0.000112	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CXCL8—ulcerative colitis	2.13e-05	0.000109	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—TP53—ulcerative colitis	2.05e-05	0.000105	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—IL2—ulcerative colitis	2.04e-05	0.000104	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—IL6—ulcerative colitis	2.03e-05	0.000104	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—PPARG—ulcerative colitis	1.98e-05	0.000101	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—STAT3—ulcerative colitis	1.98e-05	0.000101	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—MMP9—ulcerative colitis	1.93e-05	9.86e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—NFKB1—ulcerative colitis	1.91e-05	9.75e-05	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—IL6—ulcerative colitis	1.87e-05	9.57e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—TGFB1—ulcerative colitis	1.83e-05	9.35e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—ALB—ulcerative colitis	1.78e-05	9.1e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—STAT3—ulcerative colitis	1.72e-05	8.76e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—PPARG—ulcerative colitis	1.68e-05	8.58e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—TGFB1—ulcerative colitis	1.59e-05	8.12e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—PTGS2—ulcerative colitis	1.56e-05	7.97e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—ALB—ulcerative colitis	1.51e-05	7.71e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—TP53—ulcerative colitis	1.51e-05	7.7e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—IL6—ulcerative colitis	1.38e-05	7.05e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—PTGS2—ulcerative colitis	1.32e-05	6.75e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—TP53—ulcerative colitis	1.31e-05	6.69e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—IL6—ulcerative colitis	1.2e-05	6.12e-05	CbGpPWpGaD
